Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 796

1.

Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer.

Meyers BF, Haddad F, Siegel BA, Zoole JB, Battafarano RJ, Veeramachaneni N, Cooper JD, Patterson GA.

J Thorac Cardiovasc Surg. 2006 Apr;131(4):822-9; discussion 822-9. Epub 2006 Mar 2.

PMID:
16580440
2.

Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.

Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):615-9. doi: 10.1016/j.jtcvs.2007.09.029. Epub 2008 Jan 11.

PMID:
18329480
3.

Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer.

Sanli M, Isik AF, Zincirkeser S, Elbek O, Mete A, Tuncozgur B, Elbeyli L.

J Thorac Cardiovasc Surg. 2009 Nov;138(5):1200-5. doi: 10.1016/j.jtcvs.2009.03.035. Epub 2009 Jun 18.

PMID:
19660381
5.

Positron emission tomography with selected mediastinoscopy compared to routine mediastinoscopy offers cost and clinical outcome benefits for pre-operative staging of non-small cell lung cancer.

Yap KK, Yap KS, Byrne AJ, Berlangieri SU, Poon A, Mitchell P, Knight SR, Clarke PC, Harris A, Tauro A, Rowe CC, Scott AM.

Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1033-40. Epub 2005 May 5.

PMID:
15875178
6.

Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.

Cerfolio RJ, Bryant AS.

Ann Thorac Surg. 2008 Aug;86(2):362-6; discussion 366-7. doi: 10.1016/j.athoracsur.2008.04.042.

PMID:
18640297
7.

Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer.

Lee PC, Port JL, Korst RJ, Liss Y, Meherally DN, Altorki NK.

Ann Thorac Surg. 2007 Jul;84(1):177-81.

PMID:
17588407
8.

Outcomes and cost-effectiveness of alternative staging strategies for non-small-cell lung cancer.

Esnaola NF, Lazarides SN, Mentzer SJ, Kuntz KM.

J Clin Oncol. 2002 Jan 1;20(1):263-73.

PMID:
11773178
9.

Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.

Al-Sarraf N, Aziz R, Gately K, Lucey J, Wilson L, McGovern E, Young V.

Eur J Cardiothorac Surg. 2008 Jan;33(1):104-9. Epub 2007 Oct 30.

PMID:
17977738
10.

Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography.

Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ.

J Thorac Cardiovasc Surg. 1996 Mar;111(3):642-8.

PMID:
8601980
11.

The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.

Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.

Clin Nucl Med. 2007 Aug;32(8):607-12.

PMID:
17667432
12.

Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients.

Carnochan FM, Walker WS.

Eur J Cardiothorac Surg. 2009 May;35(5):781-4; discussion 784-5. doi: 10.1016/j.ejcts.2009.01.031. Epub 2009 Mar 9.

PMID:
19272791
13.

The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.

Vesselle H, Pugsley JM, Vallières E, Wood DE.

J Thorac Cardiovasc Surg. 2002 Sep;124(3):511-9.

PMID:
12202868
14.

Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?

Hayashi K, Abe K, Yano F, Watanabe S, Iwasaki Y, Kosuda S.

Ann Nucl Med. 2005 Jul;19(5):393-8.

PMID:
16164196
15.

Transbronchial needle aspiration in lung cancer patients suitable for operation with positive mediastinal positron emission tomography.

Melloni G, Casiraghi M, Bandiera A, Ciriaco P, Carretta A, Libretti L, Zannini P.

Ann Thorac Surg. 2009 Feb;87(2):373-8. doi: 10.1016/j.athoracsur.2008.10.081.

PMID:
19161740
16.

Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes.

Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V.

Lung Cancer. 2008 Apr;60(1):62-8. Epub 2007 Oct 24.

PMID:
17920724
17.

[Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].

Wang X, Zheng L, Zhang SY, Xie ZM, Yu H, Su XD, Wang JY, Huang ZF, Yang MT, Rong TH.

Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):456-9. Chinese.

PMID:
19950559
18.

Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy.

Eloubeidi MA, Tamhane A, Chen VK, Cerfolio RJ.

Ann Thorac Surg. 2005 Oct;80(4):1231-9.

PMID:
16181845
19.

Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging.

Stiles BM, Servais EL, Lee PC, Port JL, Paul S, Altorki NK.

J Thorac Cardiovasc Surg. 2009 Jan;137(1):13-9. doi: 10.1016/j.jtcvs.2008.09.045.

PMID:
19154893
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk